RETINOPATHY OF PREMATURITY
Clinical trials for RETINOPATHY OF PREMATURITY explained in plain language.
Never miss a new study
Get alerted when new RETINOPATHY OF PREMATURITY trials appear
Sign up with your email to follow new studies for RETINOPATHY OF PREMATURITY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Could a lower dose save sight in preemies?
Disease control OngoingThis study tests whether lower doses of the drug bevacizumab can effectively treat a severe form of retinopathy of prematurity (ROP) in premature infants. The trial includes 77 babies with type 1 ROP in zone I, the most severe type. Researchers will check if the treatment stops t…
Matched conditions: RETINOPATHY OF PREMATURITY
Phase: PHASE2 • Sponsor: Jaeb Center for Health Research • Aim: Disease control
Last updated May 07, 2026 18:38 UTC
-
AI boosts eye Doctors' accuracy for preemie blindness risk
Diagnosis OngoingThis study tests whether an artificial intelligence tool called i-ROP DL helps eye doctors more accurately diagnose a serious eye disease (retinopathy of prematurity) in premature babies. Sixteen eye doctors will review hundreds of eye images, some with and some without the AI's …
Matched conditions: RETINOPATHY OF PREMATURITY
Phase: NA • Sponsor: Siloam Vision • Aim: Diagnosis
Last updated May 17, 2026 06:52 UTC
-
Premature Babies' vision tracked years after eye treatment
Knowledge-focused OngoingThis study follows about 100 babies who were treated for retinopathy of prematurity (an eye disease in premature infants) in an earlier study. Researchers want to see how their eyesight and overall development are doing over the long term, and check for any delayed side effects. …
Matched conditions: RETINOPATHY OF PREMATURITY
Sponsor: Regeneron Pharmaceuticals • Aim: Knowledge-focused
Last updated May 17, 2026 06:46 UTC
-
Japanese babies with eye disease monitored on eylea in new safety study
Knowledge-focused OngoingThis observational study tracks 75 Japanese babies with retinopathy of prematurity (ROP) who are already prescribed Eylea. Researchers will collect safety and effectiveness data from routine medical visits over 6 months. The goal is to see how well Eylea works and what side effec…
Matched conditions: RETINOPATHY OF PREMATURITY
Sponsor: Bayer • Aim: Knowledge-focused
Last updated May 17, 2026 06:44 UTC